date,title,source
Oct-17-18,"Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-22-18,BiondVax Receives 8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial,PR Newswire
Oct-24-18,"BiondVax's Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season's Enrollment of 4,098 Participants",PR Newswire
Nov-13-18,BiondVax Announces Third Quarter 2018 Financial Results,PR Newswire
Nov-19-18,BiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results,PR Newswire
Nov-20-18,BVXV: Enrollment of First Season Cohort Complete in Phase 3 Trial of Universal Influenza Vaccine,Zacks Small Cap Research
Nov-26-18,BiondVax CEO to Present at 'World Vaccine Congress 2018 San Diego' About BiondVax's Phase 3 Universal Flu Vaccine Candidate,PR Newswire
